Oncocyte Corp Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Oncocyte Corp quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2019 to Q3 2023.
  • Oncocyte Corp Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2023 was $4.04M, a 15.3% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $4.04M +$537K +15.3% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $4.04M +$537K +15.3% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $3.5M $0 0% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $3.5M $0 0% Dec 31, 2022 10-Q 2023-11-09
Q3 2022 $3.5M $0 0% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $3.5M +$102K +3% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $3.5M +$102K +3% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $3.5M +$102K +3% Dec 31, 2021 10-K 2023-04-12
Q3 2021 $3.5M +$102K +3% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $3.4M $0 0% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $3.4M +$6K +0.18% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $3.4M +$541K +18.9% Dec 31, 2020 10-Q 2021-11-09
Q3 2020 $3.4M +$3M +756% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $3.4M Jun 30, 2020 10-Q 2020-07-29
Q1 2020 $3.39M Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $2.86M Dec 31, 2019 10-K 2021-03-19
Q3 2019 $397K Sep 30, 2019 10-Q 2019-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.